This proposal seeks to establish the basis for postischemic contractile dysfunction and reperfusion injury in rat and canine myocardium. The hypothesis is that postischemic contractile dysfunction or """"""""stunning"""""""" differs significantly in rat and canine hearts. In the rat, Ca 2+ overload via Na/Ca 2+ exchange causes spontaneous and uncoordinated Ca 2+ release from the sarcoplasmic reticulum throughout the cardiac cycle, undermining diastolic filling and systolic ejection. Canine myocardium, however, is less dependent on reactions of the sarcoplasmic reticulum during excitation-contraction coupling. It is also more sensitive to beta-adrenergic stimulation. This suggests that stunning of the canine myocardium may instead involve a relative deficiency of cAMP. Such a deficiency could result from phosphorylation and internalization of sarcolemmal beta-receptors in response to transient elevations in catecholamines or intracellular free [Ca 2+] . There could also be oxygen radical activation of soluble guanylyl cyclase, with cGMP-dependent stimulation of cAMP phosphodiesterase. Increases in alpha-receptors or depletion of cytosolic GTP could also depress intracellular cAMP. It follows that stunning in canine myocardium could be caused by dislocations in the myocytes per se, as might be produced by intracellular acidosis, altered energy metabolism, or mitochondrial generation of reactive oxygen radicals. Alternatively, stunning could involve the release of injurious agents from non-muscle cells or excess catecholamines from tissue storage sites. To test this hypothesis and establish the mechanisms involved in postischemic dysfunction, ventricular myocytes will be isolated from rat and canine hearts and characterized in terms of energy metabolism, ion homeostasis, oxygen radical production, excitation-contraction coupling, and hormone responsiveness prior to and following simulated ischemia and reperfusion. Similar protocols will be used to characterize cells isolated from intact myocardium subjected to ischemia and reperfusion in vitro or in vivo. Isolated rat and canine myocytes incubated under identical controlled conditions overcome many of the technical difficulties inherent in comparing large and small animal hearts and in obtaining reliable data on membrane receptor density, intracellular free Ca2+ , and cAMP content.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL036240-07
Application #
3351058
Study Section
Physical Biochemistry Study Section (PB)
Project Start
1986-09-30
Project End
1995-09-29
Budget Start
1992-09-30
Budget End
1993-09-29
Support Year
7
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
Schools of Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Houle, M S; Altschuld, R A; Billman, G E (2001) Enhanced in vivo and in vitro contractile responses to beta(2)-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias. J Appl Physiol 91:1627-37
Altschuld, R A; Billman, G E (2000) beta(2)-Adrenoceptors and ventricular fibrillation. Pharmacol Ther 88:14-Jan
Carnes, C A; Mehdirad, A A (2000) Effects of azimilide, acidemia, and the combination on defibrillation energy requirements. J Cardiovasc Pharmacol 36:283-7
Mehdirad, A A; Carnes, C A; Nelson, S D (1999) The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shock. Pacing Clin Electrophysiol 22:147-51
Hohl, C M (1999) AMP deaminase in piglet cardiac myocytes: effect on nucleotide metabolism during ischemia. Am J Physiol 276:H1502-10
Carnes, C A; Mehdirad, A A; Nelson, S D (1998) Drug and defibrillator interactions. Pharmacotherapy 18:516-25
Matlib, M A; Zhou, Z; Knight, S et al. (1998) Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. J Biol Chem 273:10223-31
Starling, R C; Hammer, D F; Altschuld, R A (1998) Human myocardial ATP content and in vivo contractile function. Mol Cell Biochem 180:171-7
Billman, G E; Castillo, L C; Hensley, J et al. (1997) Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death. Circulation 96:1914-22
Hensley, J; Billman, G E; Johnson, J D et al. (1997) Effects of calcium channel antagonists on Ca2+ transients in rat and canine cardiomyocytes. J Mol Cell Cardiol 29:1037-43

Showing the most recent 10 out of 41 publications